An international research team led by the Hong Kong University of Science and Technology (HKUST) has reportedly developed a groundbreaking blood test for the early detection of Alzheimer’s disease (AD) and mild cognitive impairment (MCI) with remarkable accuracy rates. Key features: Unlike current blood tests that focus on a single biomarker to determine brain pathology, the new test measures the levels of 21 proteins in multiple AD-associated biological pathways, allowing for a more accurate assessment and monitoring of disease progression.
Related Keywords
Singapore , Barcelona , Comunidad Autonoma De Cataluna , Spain , China , London , City Of , United Kingdom , Hong Kong , Chinese , Nancy Ip Yuk Yu , Yao Ming , Hong Kong University Of Science , Journal Of The Alzheimer Association , Hong Kong Centre For Neurodegenerative Diseases , South China Morning Post , Hong Kong University , Lunar New , Cognitact Limited , Hong Kong Centre , Neurodegenerative Diseases , Alzheimers Disease , Blood Test , Hong Kong University Of Science And Technology , Hkust , D , International Research Team , Ccuracy Rates , Disease Progression , Chinese Dragon , Mild Cognitive Impairment ,
comparemela.com © 2020. All Rights Reserved.